C-Suite Leadership Strategy · The Next Chapter

Chief Strategy Officer Moving Into Consulting? How to Win a Commoditised Market

You owned the M&A, the capital allocation and the bets the enterprise lived or died by. Now you want to advise on strategy — the single most crowded, most commoditised thing anyone sells.

You are the strategy leader who ran corporate development, sat on the deals, made the capital-allocation calls and then lived with their consequences for years. Now you want to advise founders, boards and funds on exactly those decisions. The problem is unique to you: strategy is what McKinsey, BCG and ten thousand ex-consultants already sell, and a former CSO offering strategy sounds like more of the same. This engagement packages a strategy leader's rare, lived edge into a practice the framework firms cannot copy.

For
The operating CSO moving into advisory
The trap
Strategy as the most commoditised offer there is
The shift
Strategy chief → an edge the firms cannot copy
Investment
₹29,500 incl. GST / $250

Does this sound like you?

If several of these land, this engagement is built for you.

  • You have decided to advise on strategy, M&A and capital allocation, and you keep hitting the same wall — everyone from the Big Three to every laid-off consultant already sells strategy.
  • When you describe your offer, it comes out as strategy advisory, and you can hear how indistinguishable that sounds from the thousand other people saying it.
  • You know your real edge is that you lived with your strategies for years, but you have no way to make that legible against a slick firm with a famous logo and a big team.
  • You are tempted to compete on frameworks and decks, and you sense you would lose that fight to people who do frameworks and decks all day.
  • Boards and CEOs seem to reflexively reach for a brand-name firm for the big strategic question, and you cannot see the wedge that gets a former CSO into that room instead.
  • You suspect that trying to be a generalist strategy advisor is exactly the way to be invisible, but you have not identified the narrow, defensible thing that is unmistakably yours.
01

Why strategy is the worst thing a CSO can sell as a category

The Chief Strategy Officer moving into consulting confronts a paradox the other operators are spared: the field they mastered is the most crowded advisory market in existence. Strategy is what the brand-name firms were built to sell, what every business school trains people to sell, and what every downsized consultant reaches for on the way out. To offer strategy advisory as a former CSO is to walk into the single most contested category holding a proposition that sounds, from the outside, identical to everyone else's. The record is towering and the label is fatal — because the label places you in a sea of framework-sellers where a famous logo and a large team beat a distinguished individual almost every time.

The deeper trap is that the CSO's instinct is to compete on exactly the ground where they are weakest. A strategy chief is comfortable with frameworks, market maps and elegant option analysis, so the natural move is to lead with them — and that is precisely the fight to avoid, because the firms do frameworks industrially, with pyramids of analysts and a brand that boards were conditioned to trust. Meeting them there, a single former CSO is a worse version of what they already buy. The commoditisation is not in your ability; it is in the category you are reaching for, and the whole transition depends on refusing to compete inside it.

02

What boards and CEOs actually buy that the firms cannot supply

The boards, CEOs, founders and funds who might hire a former CSO over a brand-name firm are not, in those moments, buying analysis — the firms supply analysis better and cheaper at scale. They are buying something the firms structurally cannot: the judgement of someone who has personally owned a strategic decision and lived with its consequences long after the deck was delivered. A consultant recommends the acquisition and leaves; you integrated it, watched the synergy case meet reality, and carry the scar. A firm sizes the market-entry option; you made the bet, funded it against competing priorities, and answered to the board when it turned. That lived accountability for outcomes — not for recommendations — is scarce, un-staffable, and exactly what a decision-maker wants beside them when the stakes are personal.

The CSO's error is to sell the analysis they share with the firms rather than the ownership only they have. A defensible strategy practice productises around that ownership, narrowly.

  • M&A and corporate-development judgement — not deal analysis, but the counsel of someone who has integrated deals and lived the synergy case meeting reality.
  • Capital-allocation advisory — helping a board choose between competing bets from the seat of someone who has made those calls and owned the outcome.
  • Owner-side strategic counsel — a trusted advisor to a CEO or promoter on the decisions they cannot outsource to a firm, priced as a relationship.
  • Sector- or decision-type niche — a narrow, defensible specialism where lived experience beats general frameworks, not strategy in general.
03

The cost of competing as a generic strategy advisor

The strategy leader's instinct on leaving is to keep the aperture wide — to offer strategy broadly, because breadth feels like more addressable market and narrowing feels like turning away work. In the most commoditised category on earth, breadth is invisibility. A generic strategy advisor is indistinguishable from the field, loses the brand comparison to the firms every time, and gives a board no reason to reach past the logo they already trust. Every month spent as a generalist strategy consultant is a month building no distinctive association, no reason to be remembered, and no wedge into the room — you are competing in an ocean precisely by refusing to leave it.

There is a compounding cost in how the market files you. Positioned as generic strategy, your referrals — if any come — arrive for undifferentiated strategy work you will win only on price or personal favour, neither of which sustains a premium practice. Meanwhile the narrow, defensible practice you could have built, where your lived ownership makes you the obvious and only choice, never forms, because your positioning invited comparison instead of foreclosing it. The window to claim a distinctive strategic niche is widest at the start, while your last mandate is fresh and specific in the market's mind. It narrows into generic strategy advisor — the most forgettable phrase in professional services — with every month the aperture stays wide.

04

The reframe: sell the scar, not the framework

The repositioning does not ask you to disown the analytical rigour of the strategy seat — that rigour is the price of entry. It asks you to stop leading with the one thing you share with everyone you are competing against. The proposition that drowns the CSO is I advise on strategy — a claim the whole market makes and the firms make louder. The proposition that wins is I have owned this exact decision and lived its consequences, and I will sit with you while you own yours — a claim no framework-seller can make because they have never carried an outcome past the presentation. You are not selling better analysis than the firms; you are selling the judgement that only comes from having been accountable long after the analysis was done.

This is the CSO's structural advantage over both the brand-name firms and the flood of ex-consultants, and it is decisive when it is made legible. The firms sell recommendation-at-scale; the ex-consultants sell more of the same with a smaller logo; you sell ownership, which neither can. A board wrestling with a company-defining acquisition does not, in the end, want another market map — it wants someone in the room who has personally integrated a deal that looked just as good on paper and knows where the bodies were buried. Reframed, you are not a former CSO competing in the strategy market. You are the rare advisor who has lived the decision the client is about to make, and the task is to narrow and position that so it becomes the reason a board reaches past the logo.

The firms sell the framework; you sell the scar. A board facing a bet-the-company decision does not want another market map — it wants someone who has personally lived through the same call and knows where it goes wrong. That is the one thing a pyramid of analysts and a famous logo can never staff.

05

Building a practice narrow enough to be unmistakable

The final piece is the discipline the breadth of the strategy seat never demanded: narrowing to the point of being unmistakable. A defensible strategy practice is not built by widening to catch more market but by narrowing to a specific decision type or sector where your lived ownership makes the comparison to a firm absurd — the person who has integrated deals in this industry, or made capital-allocation calls at this kind of inflection, not a generalist available for any strategic question. Paired with that narrowness is a small set of relationships — chairs, CEOs, promoters, fund partners — who know the precise decision you are the person for. In a commoditised field, the narrow, owned wedge is the only thing that defeats the logo, and it is entirely designable.

This engagement is built to find and cut that wedge. Across two partner conversations, a diagnosis and a written roadmap, we separate the analysis you share with the firms from the lived ownership only you have, narrow your practice to the decision type or sector where that ownership is unbeatable, and design the positioning and relationships that make a board reach past the brand-name firm for you. The aim is a practice so specific and so credibly owned that it does not compete in the strategy market at all — so the next chapter is a distinctive advisory business built on your scars, not a distinguished strategist lost in the most crowded category in professional services.

How it plays out

The strategist who sold the deal he had lived, not the deck

Consider a Chief Strategy Officer — call him K — who had run corporate development for a large Indian pharmaceutical group, leading a decade of acquisitions and the capital-allocation calls that shaped the portfolio, then living with every one of them through integration and beyond. He left to advise, offering, naturally, strategy and M&A advisory. The response was a wall of silence. Boards that needed strategic help reached reflexively for a brand-name firm, and the few conversations he had ended in polite comparison to exactly those firms — a comparison a single individual with no logo and no analyst team was never going to win. His record was extraordinary and his proposition was invisible.

The diagnosis was blunt about why. K was selling the one thing he shared with everyone he was competing against — strategy analysis — in the most crowded market in professional services, and leading with the frameworks the firms produce industrially. He had made his real edge invisible: he had not merely advised on pharma acquisitions, he had integrated them, watched the synergy cases collide with regulatory and commercial reality, and answered to a board for the ones that disappointed. That lived ownership was un-staffable and unique to him, and he had buried it under a generic label that invited the very comparison he could not survive.

The roadmap cut a narrow, defensible wedge. K stopped offering strategy and began offering something no firm could claim: counsel to pharma and healthcare boards on acquisitions and licensing bets, from someone who had personally integrated a dozen of them and knew exactly where they go wrong after the deck is signed. He narrowed to that decision type and sector until the comparison to a brand-name firm became absurd, and he cultivated a short set of chairs and promoters who knew he was the person for precisely that call. Within a year K was being brought into bet-the-company pharma deals ahead of the firms, sought for the scar tissue no analyst team could supply. He had stopped selling the deck. He had started selling the deals he had lived.

Illustrative composite — every engagement is calibrated to your specific situation.

What the two conversations cover

Session 1 · Diagnosis

  • Separate the analysis you share with the firms from the lived ownership only you have — the decisions you made and carried, not merely advised on.
  • Identify the buyers who would reach past a brand-name firm for a former CSO — the boards, CEOs and funds, and the exact decisions they cannot outsource.
  • Locate the commoditisation trap: where offering strategy broadly makes you invisible, and the narrow wedge where your ownership is unbeatable.

Session 2 · The plan

  • Narrow the practice to a decision type or sector where lived ownership makes the comparison to a framework firm absurd, not strategy in general.
  • Reframe the offer around the scar rather than the deck — the judgement of someone who has owned the outcome, which no firm can staff.
  • Design the positioning and the short set of relationships that make a board reach past the logo for you on the decisions that matter most.

The mistakes to avoid

  • Offering strategy advisory as a category, walking into the most crowded market in professional services with a proposition that sounds like everyone else's.
  • Competing on frameworks and decks against firms that produce them industrially with analyst pyramids and a logo boards were trained to trust.
  • Keeping the aperture wide because breadth feels like more market, when in a commoditised field breadth is invisibility.
  • Leading with the analysis you share with the firms instead of the lived ownership only you have, inviting the comparison you cannot win.
  • Assuming a towering CSO record speaks for itself, when a generic label buries the very scar tissue that would make you the obvious choice.

One offering · one outcome

  • Two 60-minute one-to-one conversations with a senior Gladwin partner
  • A complete diagnostic of where you stand in the market today
  • A personalised repositioning roadmap you keep — your gap analysis and 90-day plan
Book and pay online

C-Suite Leadership Strategy — Assessment and Roadmap

2 × 60-minute conversations · one booking

₹29,500incl. GST · per booking
  • Two 60-minute one-to-one conversations with a senior Gladwin partner
  • A complete diagnostic of where you stand in the market today
  • A personalised repositioning roadmap you keep — your gap analysis and 90-day plan
Pay in:

Loading available slots…

Frequently Asked Questions

By refusing to compete in the strategy category at all. Strategy is what the brand-name firms and every ex-consultant already sell, so offering it broadly makes you invisible. Instead you narrow to a decision type or sector where your lived ownership — deals you integrated, capital-allocation calls you carried — makes the comparison to a firm absurd. You sell the judgement of someone who has owned the outcome, not the analysis anyone can supply. The transition fails when you lead with frameworks; it works when you sell the scar only you have.

You do not compete with them on their ground, because a single individual with no logo and no analyst team loses that comparison every time. You compete on the one thing they structurally cannot supply: having personally owned a decision and lived its consequences long after the deck was delivered. A board facing a bet-the-company call eventually wants someone in the room who has made the same call and knows where it goes wrong, not another market map. That ownership is un-staffable, and it is the wedge that gets you past the logo.

It feels that way and it is the opposite. In the most crowded category in professional services, breadth is invisibility — a generic strategy advisor gives a board no reason to remember them or reach past the firm they already trust. Narrowing to the decision type or sector where your lived ownership is unbeatable is what makes you the obvious and only choice for that decision. You are not shrinking the market; you are claiming a wedge you can actually win, instead of an ocean you cannot. Specificity, not breadth, is what defeats the logo.

By leading with the ownership, not the analysis — framing every offer around having carried the outcome rather than having produced the recommendation. You integrated the deal that looked perfect on paper; you funded the bet against competing priorities and answered for it; you know where the synergy case meets reality. Stated as the specific, sector-anchored judgement of someone who has been accountable long after the deck, it becomes something no framework-seller can claim. The diagnosis surfaces those scars precisely so they become your proposition rather than an untold story.

Rigour is the price of entry, not the pitch. Leading with frameworks puts you on exactly the ground where the firms are strongest and you are weakest — they do frameworks industrially, and a single former CSO is a lesser version of what a board already buys there. Keep the rigour as the assumed foundation and lead instead with lived ownership, which the firms cannot match. Competing on analysis is how a distinguished strategist becomes indistinguishable; competing on owned outcomes is how they become irreplaceable for the decisions that matter.

It sells ownership, narrowly. Concrete forms include M&A and corporate-development counsel from someone who has integrated deals and lived the synergy case; capital-allocation advisory to boards choosing between competing bets from a seat that has made those calls; trusted owner-side strategic counsel to a CEO or promoter on decisions they cannot outsource; and a sharp sector or decision-type niche where lived experience beats general frameworks. Each is priced as judgement and relationship, not analysis by the hour. The roadmap turns your record into that specific, defensible menu.

Yes, and the fit is strong. Indian promoter and family groups facing consolidation, acquisitions and capital-allocation inflections often want a trusted individual who has lived those decisions over a brand-name firm they experience as detached. A former CSO who has run corporate development through the same journey is scarce and credible, and the relationship-carried nature of Indian boardrooms rewards a narrow, owned wedge. The specific niche is built around your sector and the decisions you have carried, but the sell-the-scar-not-the-framework logic holds across markets.

Two 60-minute conversations with a partner, a written diagnostic separating the analysis you share with the firms from the lived ownership only you have, and a personalised roadmap document — the narrow decision-type or sector wedge to claim, the offer reframed around owned outcomes rather than frameworks, and the positioning and relationships that make a board reach past a brand-name firm for you. One price, incl. GST, or $250 internationally. No tiers and nothing further to buy.